- Tests for the coronavirus in the US will undergo expansion following the approval of new test kits by the Food and Drug Administration (FDA)
- Currently, the US lags behind in testing of its citizens for Covid-19
- One of the approved tests, Cepheid’s COVID-19, has been dedicated to frontline tests by hospitals and clinics
The Food and Drug Administration (FDA) of the United States of America (USA) has initiated moves to ensure that tests for the coronavirus could be expanded all over the country.
The FDA is, therefore, granting a special ‘emergency use authorisation’ for tests and equipment.
Briefly.co.za understands that the USA lags behind several countries around the world with regard to tests conducted relative to its population size.
One of the tests approved, Cepheid’s COVID-19 test is capable of expanding the availability of frontline tests in hospitals and clinics, techcrunch.com reports.
The test is also capable of being run with or without the use of a nasal swab, which is key because supplies of nasal swabs are taxed globally in light of the need for testing.
Testing has gradually increased in the USA, mainly because of efforts at expanding availability in the hardest-hit areas such as New York state.
There is nonetheless an urgent need for more tests as health professionals usually focus on the most severe cases, which usually require contact tracing or proof of elevated risk.
Meanwhile, as the coronavirus spreads across the world and the death toll climbs every day, health experts have been working to develop a vaccine to combat the deadly virus.
The efforts appear to be yielding results as the United States government announced that a clinical trial to test a coronavirus vaccine had begun on Monday.
The first human participant would receive an experimental dose to test for potential side-effects, but they will not actually be infected with the Covid-19 virus, according to the source.
The vaccine trial will be carried out on 45 young, healthy volunteers in different doses, which were co-developed by the NIH and Moderna Inc.
Those who participate in the trial won't get infected as the shots do not contain the deadly virus.
The goal of the trial is to find out if the vaccines have worrisome side-effects before expanding the tests to more people.
Enjoyed reading our story? Download BRIEFLY's news app on Google Play now and stay up-to-date with major South African news!